The mechanism of Gualou Xiebai Baijiu decoction in the treatment of myocardial reperfusion injury based on network pharmacology and molecular docking technology

Linfeng Wu; Jidan Fan

doi:10.54254/3029-0821/2/2024018

Research Article

Open access

Published on 20 September 2024

Download pdf

Wu,L.;Fan,J. (2024). The mechanism of Gualou Xiebai Baijiu decoction in the treatment of myocardial reperfusion injury based on network pharmacology and molecular docking technology. Journal of Food Science, Nutrition and Health,2,54-60.

Export citation

The mechanism of Gualou Xiebai Baijiu decoction in the treatment of myocardial reperfusion injury based on network pharmacology and molecular docking technology

Linfeng Wu ¹, Jidan Fan *^,2,

¹ Southwest Medical University
² Taizhou People's Hospital Affiliated to Nanjing Medical University

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/3029-0821/2/2024018

Abstract

To explore the effective components and mechanism of Gualou Xiebai Baijiu decoction (GLXB) in the treatment of myocardial ischemia-reperfusion injury (MIRI) based on network pharmacology and molecular docking approach.

Keywords

Gualou Xiebai Baijiu decoction, myocardial reperfusion injury, molecular docking, molecular targets, network pharmacology

View pdf

References

[1]. Schulze, C. J., Wang, W., Suarez-Pinzon, W. L., Sawicka, J., Sawicki, G., & Schulz, R. (2003). Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury. Circulation, 107(19), 2487–2492. https://doi.org/10.1161/01.CIR.0000065603.09430.58

[2]. Hernandez-Resendiz, S., Chinda, K., Ong, S. B., Cabrera-Fuentes, H., Zazueta, C., & Hausenloy, D. J. (2018). The role of redox dysregulation in the inflammatory response to acute myocardial ischaemia-reperfusion injury - Adding fuel to the fire. Current Medicinal Chemistry, 25(11), 1275–1293. https://doi.org/10.2174/0929867324666170329100619

[3]. Zhou, H., Wang, J., Zhu, P., Hu, S., & Ren, J. (2018). Ripk3 regulates cardiac microvascular reperfusion injury: The role of IP3R-dependent calcium overload, XO-mediated oxidative stress and F-action/filopodia-based cellular migration. Cellular Signalling, 45, 12–22. https://doi.org/10.1016/j.cellsig.2018.01.020

[4]. Ashraf, M. I., Ebner, M., Wallner, C., Haller, M., Khalid, S., Schwelberger, H., Koziel, K., Enthammer, M., Hermann, M., Sickinger, S., Soleiman, A., Steger, C., Vallant, S., Sucher, R., Brandacher, G., Santer, P., Dragun, D., & Troppmair, J. (2014). A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury. Cell Communication and Signaling, 12, 6. https://doi.org/10.1186/1478-811X-12-6

[5]. Hausenloy, D. J., & Yellon, D. M. (2013). Myocardial ischemia-reperfusion injury: A neglected therapeutic target. The Journal of Clinical Investigation, 123(1), 92–100. https://doi.org/10.1172/JCI62874

[6]. Yang, M., Linn, B. S., Zhang, Y., & Ren, J. (2019). Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1865(9), 2293–2302. https://doi.org/10.1016/j.bbadis.2019.05.007

[7]. Li, C. Y., Yang, P., Jiang, Y. L., Lin, Z., Pu, Y. W., Xie, L. Q., Sun, L., & Lu, D. (2020). Ginsenoside Rb1 attenuates cardiomyocyte apoptosis induced by myocardial ischemia-reperfusion injury through mTOR signal pathway. Biomedicine & Pharmacotherapy, 125, 109913. https://doi.org/10.1016/j.biopha.2020.109913

[8]. Gao, F., Jing, Y., Li, J., & Guo, J. (2018). Therapeutic efficacy of Gualou Xiebai Banxia decoction in the treatment of angina pectoris: A systematic review. Journal of Integrated Cardiovascular and Cerebrovascular Diseases of Chinese and Western Medicine. https://doi.org/10.12102/j.issn.1672-1349.2018.23.003

[9]. Zou, C., Wel, M., Yan, H., Zheng, C., & Xu, X. (2020). Effects of Gualou Xiebai dropping pills against myocardial ischemia reperfusion injury. Journal of International Pharmaceutical Research, 05, 926-930. https://doi.org/10.13220/j.cnki.jipr.2016.05.022

[10]. Du, Y. (2020). Effect of Gualou Xiebai Banxia decoction on the efficacy and immune function of patients with hypertension and coronary heart disease. Inner Mongolia Traditional Chinese Medicine, 39(09), 24-25. https://doi.org/10.16040/j.cnki.cn15-1101.2020.09.014

[11]. Gualou Xiebai Banxia Decoction in the treatment of patients with hypertension combined with coronary heart disease and the effect on immune function. (2020). Cardiovascular Disease Electronic Journal of Integrated Traditional Chinese and Western Medicine, 35, 161+182. https://doi.org/10.16282/j.cnki.cn11-9336/r.2020.35.119

[12]. Xu, L., Li, H., Gao, Z., & Zhao, Q. (2014). Experimental study of blood lipid-regulating and myocardium-protecting function of Gualou Xiebai Banxia decoction. Journal of Shandong University of Traditional Chinese Medicine, 38(06), 593-595. https://doi.org/10.16294/j.cnki.1007-659x.2014.06.030

[13]. Ding, Y. F., Peng, Y. R., Shen, H., Shu, L., & Wei, Y. J. (2016). Gualou Xiebai decoction inhibits cardiac dysfunction and inflammation in cardiac fibrosis rats. BMC Complementary and Alternative Medicine, 16, 49. https://doi.org/10.1186/s12906-016-1012-5

[14]. Yan, L. L., Zhang, W. Y., Wei, X. H., Yan, L., Pan, C. S., Yu, Y., Fan, J. Y., Liu, Y. Y., Zhou, H., Han, J. Y., & Yao, X. S. (2018). Gualou Xiebai decoction, a traditional Chinese medicine, prevents cardiac reperfusion injury of hyperlipidemia rat via energy modulation. Frontiers in Physiology, 9, 296. https://doi.org/10.3389/fphys.2018.00296

[15]. Hopkins, A. L. (2007). Network pharmacology. Nature Biotechnology, 25(10), 1110–1111. https://doi.org/10.1038/nbt1007-1110

[16]. Hopkins, A. L. (2008). Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology, 4(11), 682–690. https://doi.org/10.1038/nchembio.118

[17]. Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., Li, P., Guo, Z., Tao, W., Yang, Y., Xu, X., Li, Y., Wang, Y., & Yang, L. (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6, 13. https://doi.org/10.1186/1758-2946-6-13

[18]. UniProt Consortium. (2021). UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Research, 49(D1), D480–D489. https://doi.org/10.1093/nar/gkaa1100

[19]. von Mering, C., Jensen, L. J., Snel, B., Hooper, S. D., Krupp, M., Foglierini, M., Jouffre, N., Huynen, M. A., & Bork, P. (2005). STRING: Known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Research, 33(Database issue), D433–D437. https://doi.org/10.1093/nar/gki005

[20]. Huang, daW., Sherman, B. T., & Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4(1), 44–57. https://doi.org/10.1038/nprot.2008.211

[21]. Zhang, F., Duan, B., Zhou, Z., Han, L., Huang, P., Ye, Y., Wang, Q., Huang, F., & Li, J. (2022). Integration of metabolomics and transcriptomics to reveal anti-chronic myocardial ischemia mechanism of Gualou Xiebai decoction. Journal of Ethnopharmacology, 297, 115530. https://doi.org/10.1016/j.jep.2022.115530

[22]. Huang, S., Guo, Y., Zhao, Y., Liu, Y., Ying, G., Liu, Y., & Tang, Y. (2021). Exploration of the adjuvant effect of white liquor in Gualou Xiebai Baijiu decoction on protecting ischemic myocardium in mice based on NO3--NO2--NO pathway. Journal of Liaoning University of Traditional Chinese Medicine, 23(04), 23-27. https://doi.org/10.13194/j.issn.1673-842x.2021.04.007

[23]. Donghai, C., & Zhenqiu, Z. (2019). Study on protective effects of Pericarpium Trichosanthis extract on H9c2 myocardial cells injured by hypoxia/reoxygenation and its mechanism. China Pharmacy, 30(8), 1072-1078. https://doi.org/10.6039/j.issn.1001-0408.2019.08.12

Cite this article

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Journal：Journal of Food Science, Nutrition and Health

Volume number: Vol.2

ISSN：3029-0821(Print) / 3029-083X(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).